MSH2 and colorectal carcinoma: Among the 29 CRC patients with dMMR, 51.70% had combined MLH1 and PMS2 deletions, 24.10% had combined MSH2 and MSH6 deletions, and 3.40% had combined MSH2, MSH6 and PMS2 deletions.